185 related articles for article (PubMed ID: 31647396)
1. Anti-Alzheimer's Materials Isolated from Marine Bio-resources: A Review.
Rathnayake AU; Abuine R; Kim YJ; Byun HG
Curr Alzheimer Res; 2019; 16(10):895-906. PubMed ID: 31647396
[TBL] [Abstract][Full Text] [Related]
2. The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer's Disease.
Yan H; Feng L; Li M
Drug Des Devel Ther; 2023; 17():3295-3323. PubMed ID: 38024535
[TBL] [Abstract][Full Text] [Related]
3. Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer's Disease.
Olasehinde TA; Olaniran AO; Okoh AI
Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31731422
[TBL] [Abstract][Full Text] [Related]
4. Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review.
Lee JY; Wong CY; Koh RY; Lim CL; Kok YY; Chye SM
Yale J Biol Med; 2024 Jun; 97(2):205-224. PubMed ID: 38947104
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
Pavía J; de Ceballos ML; Sanchez de la Cuesta F
Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease.
Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
[TBL] [Abstract][Full Text] [Related]
9. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
Madav Y; Wairkar S; Prabhakar B
Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
[TBL] [Abstract][Full Text] [Related]
10. Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.
Calcul L; Zhang B; Jinwal UK; Dickey CA; Baker BJ
Future Med Chem; 2012 Sep; 4(13):1751-61. PubMed ID: 22924511
[TBL] [Abstract][Full Text] [Related]
11. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
12. Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease.
Moosavi B; Mousavi B; Macreadie IG
J Alzheimers Dis; 2015; 47(1):9-16. PubMed ID: 26402750
[TBL] [Abstract][Full Text] [Related]
13. Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.
Ułamek-Kozioł M; Pluta R; Bogucka-Kocka A; Januszewski S; Kocki J; Czuczwar SJ
Pharmacol Rep; 2016 Jun; 68(3):582-91. PubMed ID: 26940197
[TBL] [Abstract][Full Text] [Related]
14. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
Xin SH; Tan L; Cao X; Yu JT; Tan L
Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319
[TBL] [Abstract][Full Text] [Related]
15. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
16. An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds.
Zanforlin E; Zagotto G; Ribaudo G
Curr Med Chem; 2017 Nov; 24(34):3749-3773. PubMed ID: 28707586
[TBL] [Abstract][Full Text] [Related]
17. Application of Marine Natural Products against Alzheimer's Disease: Past, Present and Future.
Hu D; Jin Y; Hou X; Zhu Y; Chen D; Tai J; Chen Q; Shi C; Ye J; Wu M; Zhang H; Lu Y
Mar Drugs; 2023 Jan; 21(1):. PubMed ID: 36662216
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony.
Forner S; Baglietto-Vargas D; Martini AC; Trujillo-Estrada L; LaFerla FM
Trends Neurosci; 2017 Jun; 40(6):347-357. PubMed ID: 28494972
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of Alzheimer's disease diagnosis and treatment.
Weller J; Budson A
F1000Res; 2018; 7():. PubMed ID: 30135715
[TBL] [Abstract][Full Text] [Related]
20. Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein.
Panza F; Solfrizzi V; Frisardi V; Imbimbo BP; Capurso C; D'Introno A; Colacicco AM; Seripa D; Vendemiale G; Capurso A; Pilotto A
Aging Clin Exp Res; 2009 Dec; 21(6):386-406. PubMed ID: 20154508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
